SAJA pharmaceutical manufacturing facility is located in the industrial zone of Jeddah, the site is 32,000 sq. m., operated by more than 200 highly qualified professionals. SAJA is a full manufacturing facility that produces solid dosage form (tablet and capsule), all the processes required that include granulation, blending, tableting, encapsulation, Inspection (visual/automated), coating and automated packaging lines supported with serialization and aggregation are available in this site. Alongside we are proud of our state of art dedicated area for secondary packaging helping our partners with the first step towards localization. SAJA is equipped with the most advanced machinery and equipment to manufacture and maintain high-quality standards. From this facility, the produced goods reach everywhere across Saudi Arabia and the MENA region.
Delivering safe and effective products to patients and consumers is a fundamental element of SAJA’s Mission. Since quality is our priority, SAJA invested heavily to ensure the highest priority is placed on the safety, efficacy, and reliability of its products, the safety of our patients, consumers, and all related stakeholders. All of our employees are committed to maintaining a high-quality standard with appropriate systems and processes in place to drive quality-focused behaviors and ensure best for product quality, patient and consumer safety, and protection of our reputation and business. SAJA is using the latest technology to manage and control all aspects of quality through its computerized quality management system QMS in order to meet regulatory requirements. We strictly follow cGMP guidelines and regulations. Our performance is monitored and regularly reviewed to ensure products, quality and facility are up to standard.
SAJA OHS management system is ISO 45001:2018 certified, we have always maintained an intense focus on Occupational Health & Safety and comply with ISO 45001: 2018 requirements. We are looking forward to continually improve and sustain the EHS system which will ensure Management & Leadership commitment along with workers’ participation at all levels of SAJA Pharmaceuticals.
SAJA R&D center is equipped with a talented team and up-to-date instruments/equipment that enables us to develop robust high quality, safe and effective products that address patient’s needs. An enduring commitment to high quality drives our objective to develop products that meet emerging international standards through the implementation of integrated development models. R&D uses Design of Experiment (DoE) and Quality by design (QbD) concepts to ensure robust performance through the whole product lifecycle. SAJA has solid experience in technology transfer gained over long years of cooperation with our Japanese partners. SAJA initiated a project to have a state of art regional R&D center to meet the needs of ambitious future expansion plans.